RBC Capital lifts Life Time Group stock target to $31 from $27
The RBC Capital analyst noted the positive aspects of Life Time Group's announcement, stating that there was little to ...
RBC Capital holds Boston Scientific stock Outperform rating
In a recent update, RBC Capital analysts have maintained their Outperform rating on Boston Scientific (NYSE:BSX) shares, with ...